Summary NephroGenex Inc (NephroGenex) is a pharmaceutical company that offers development of drugs to treat kidney diseases. The company offers pyridorin is a novel acting compound used to improve treatment of diabetic nephropathy. It also offers PYR- 206, PYR- 205/207; and PYR- 210 drugs. The company offers pioneer program by securing from the FDA a fast track designation and special protocol assessment. Its products are used in the treatment of several types of acute renal failure disorders a...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.